Vivesto Signs Agreement with Visikol
Carol Tomaszewski2022-05-02T09:17:17-05:00Vivesto signs agreement with leading US CRO to evaluate anti-cancer drug formulations using its proprietary drug delivery platforms Solna, [...]
Visikol and Cancer Therapeutics
Carol Tomaszewski2022-03-18T11:52:18-05:00One in three people will be diagnosed with cancer in their lifetime, and each year in the United [...]